Underutilized Fuel: Angiotensin II for Vasoplegia in Heart Failure Patient Population

We would like to congratulate the authors of their post-hoc analysis of Angiotensin II (ANG-II) for the treatment of vasoplegia in patients following cardiac surgery.1 The study found that patients with vasoplegia after cardiac surgery with cardiopulmonary bypass rapidly responded to ANG-II with swift blood pressure response and rapid down titration of standard of care vasopressors with no reported thrombosis.1 Early recognition and treatment of vasoplegia improves survival and reduces risks of major adverse events.
Source: Journal of Cardiothoracic and Vascular Anesthesia - Category: Anesthesiology Authors: Source Type: research